iBio, Inc. IBIO Income Statement

Ibio, inc. (IBIO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
Revenues
1,313	1,744	2,081	2,018	1,314	865	367	444	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	522	864	923	948	989	959	1,192	1,851	1,740	1,391	1,024	205	617	617	617	1,007	741	1,112	1,346	1,277	1,101	0	0	-	0	-	-
Operating expenses:
Research and development (related party of $0, $217, $97 and $761), net of grant income of $0, $0, $0 and $37, respectively
4,488	4,942	5,327	5,474	4,892	4,405	4,125	3,986	4,056	4,226	4,282	4,117	3,858	3,770	3,425	3,156	3,067	2,834	2,861	3,495	3,149	2,677	2,531	1,898	2,447	2,735	2,806	3,431	3,518	4,195	4,701	4,981	5,095	4,925	4,382	3,083	0	0	0
Research and development - effect of Settlement Agreement (Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,041	-1,041	-1,041	-1,041	0	0	0	0	-	-	-	-	-	-	-	-
General and administrative (related party of $316, $288, $941 and $860)
11,952	11,635	12,447	12,332	12,103	11,864	11,058	10,685	10,584	10,816	10,580	10,551	9,833	9,399	8,732	7,685	6,957	5,776	5,394	5,022	4,511	4,240	3,989	3,888	3,903	4,181	4,169	4,243	4,733	4,751	5,457	5,623	6,884	7,565	7,066	7,090	0	0	0
General and administrative - effect of Settlement Agreement (Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-700	-700	-700	-700	0	0	0	0	-	-	-	-	-	-	-	-
Total operating expenses
16,440	16,577	17,774	17,806	16,995	16,269	15,183	14,671	14,640	15,042	14,862	14,668	13,691	13,169	12,157	10,841	10,024	8,610	8,255	8,517	7,660	6,917	6,520	4,045	4,609	5,175	5,234	7,674	8,252	8,946	10,158	10,604	11,979	12,490	11,448	10,174	0	0	0
Operating loss
-15,127	-14,833	-15,693	-15,788	-15,681	-15,404	-14,816	-14,227	-14,140	-14,583	-14,481	-14,274	-13,169	-12,305	-11,234	-9,893	-9,035	-7,651	-7,063	-6,666	-5,920	-5,526	-5,496	-3,840	-3,992	-4,558	-4,617	-6,667	-7,511	-7,833	-8,811	-9,327	-10,709	-11,416	-10,608	-9,654	0	0	0
Other income (expense):
Interest expense - related party
2,325	2,183	2,044	1,900	1,904	1,908	1,911	1,915	1,919	1,922	1,926	1,929	1,931	1,773	1,290	807	323	0	0	-	0	-	-	-	-	-	-	90	65	68	68	63	61	50	46	50	0	0	0
Interest income
23	39	58	75	66	50	31	15	19	23	31	39	46	43	33	22	12	9	10	9	7	8	7	8	9	7	7	9	11	15	14	12	10	10	13	12	0	0	0
Royalty income
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense - effect of Settlement Agreement (Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-122	-122	-122	-122	0	0	0	0	-	-	-	-	-	-	-	-
Royalty income
-	-	-	-	-	-	-	19	20	20	22	25	24	25	27	21	25	29	33	32	32	32	32	42	46	44	38	34	24	31	33	34	40	29	28	23	0	0	0
Other income (expenses)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-
Loss on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Change in fair value of warrant derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	520	8,880	7,853	6,131	3,668	-2,758	-1,984	-3,736	-2,473	0	0	0
Total other income (expense)
-2,281	-2,123	-1,969	-1,809	-1,830	-1,846	-1,864	-1,881	-1,880	-1,879	-1,873	-1,865	-1,861	-1,705	-1,230	-764	-286	38	43	41	39	43	41	174	267	876	0	-	0	0	-	0	4,813	5,587	1,666	-2,488	0	0	0
Consolidated net loss
-17,444	-16,992	-17,698	-17,597	-17,511	-17,250	-16,680	-16,108	-16,020	-16,462	-16,354	-16,139	-15,030	-14,010	-12,464	-10,657	-9,113	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to noncontrolling interest
-4	-5	-4	-4	-3	-3	-3	-3	-4	-495	-1,057	-1,607	-2,150	-2,007	-1,444	-893	-349	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) before provision for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net loss attributable to iBio, Inc.
-17,404	-16,951	-17,658	-17,593	-17,508	-17,247	-16,677	-16,105	-16,016	-15,967	-15,297	-14,532	-12,880	-12,003	-11,020	-9,764	-8,972	-7,613	-7,020	-6,625	-5,881	-5,483	-5,455	-3,666	-3,843	-4,322	-3,768	-6,198	-6,242	-7,583	-8,110	-5,676	-5,895	-5,828	-8,941	-12,142	0	0	0
Deemed dividends - down round of Series A Preferred and Series B Preferred
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred stock dividends- iBio CMO Preferred Tracking Stock
261	260	260	260	260	260	260	260	259	221	156	90	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss available to iBio, Inc.
-39,225	-38,771	-17,918	-17,853	-17,768	-17,507	-16,937	-16,365	-16,275	-16,188	-15,453	-14,622	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss:
Consolidated net loss
-17,444	-16,992	-17,698	-17,597	-17,511	-17,250	-16,680	-16,108	-16,020	-16,462	-16,354	-16,139	-15,030	-14,010	-12,464	-10,657	-9,113	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-17,404	-16,951	-17,658	-17,593	-17,508	-17,247	-16,677	-16,105	-16,016	-15,967	-15,297	-14,532	0	0	0	-	0	-	-	-6,625	-5,881	-5,483	-5,455	-3,666	-3,843	-4,322	-3,768	-6,198	-6,242	-7,583	-8,110	-5,676	-5,895	-5,828	-8,941	-12,142	0	0	0
Other comprehensive loss - foreign currency translation adjustments
-2	-1	-1	-1	-2	-1	-2	-1	0	0	0	-	-	4	5	-4	-5	-19	-31	-25	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency translation adjustments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
-17,411	-16,958	-17,663	-17,598	-17,512	-17,251	-16,682	-16,109	0	0	0	-	-	-14,006	-12,459	-10,661	-9,326	-7,632	-7,051	-6,650	-5,907	-5,497	-5,458	-3,666	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted
-0.06	-0.69	-0.21	-0.23	-0.22	-0.24	-0.25	-0.36	-0.35	-0.41	-0.42	-1.53	-0.04	-0.04	-0.03	-0.03	-0.04	-0.03	-0.02	-0.03	-0.02	-0.02	-0.02	-	-0.02	-0.03	-	-	-0.04	-0.02	-	-0.03	-0.07	-0.05	0.01	-	-0.09	-0.15	-
Weighted-average common shares outstanding - basic and diluted
79	36	21	75,648	19	18	17	12,133	11,545	9,661	9,185	-231,683	89,109	89,109	89,109	88,101	81,158	77,326	77,307	76,175	72,989	70,957	65,859	-	65,642	63,984	-	-	47,767	47,767	-	-	45,715	32,382	-	-	32,338	-	-
(Loss) income per common share - basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	-0.04	-	-	-	-	-	-	-	-0.10
(Loss) income per common share - diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	-0.04	-	-	-	-	-	-	-	-0.10
Weighted-average common shares outstanding - basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	56,692	-	-	-	47,767	-	-	-	32,382	-	-	-	28,272
Weighted-average common shares outstanding - diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60,626	-	-	-	47,767	-	-	-	34,670	-	-	-	28,272
Weighted average common shares outstanding - basic and diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30,926	-